IBD Research

Navigating the Road to Prevention

The physicians at the Susan and Leonard Feinstein IBD Center are focusing their work on helping patients suffering with IBD. The disease prevention strategies first focus on preventing flares and thus preventing patients from experiencing complications related to IBD. We create customized treatment plans based on the latest research spearheaded by members of our research team. We are continuously studying ways to predict which patients will develop symptoms and optimize their therapies before symptoms start.

Our research team has also developed a very exciting program dedicated to studying aspects of each patient’s life before developing IBD. The overall goal of this project is to define important events happening in the gastrointestinal tract before IBD happens. We plan to study populations where the risk of developing IBD is higher, namely, large families where multiple members are affected with IBD, babies born from mothers with IBD, and siblings of IBD patients.

This program will allow us to better understand why relatives from patients with IBD have a higher risk of developing the disease, and to identify key events happening before the development of the disease. We believe that the results of this study may help us understand how we can prevent the disease from ever happening, especially in these high-risk groups.

To find out more about our Life Before IBD program and the eligibility to participate in these studies please contact us at roadtoprevention@mssm.edu.

Clinical Trials Program

At our state of the art facility, patients failing current therapies can also be recruited into clinical trials and receive therapies that may change their disease course, many years before those therapies become available to the public.

If you would like to find out more about our current enrolling trials please contact us at IBDClinicaltrials@mssm.edu.

Learn more about Mount Sinai active clinical trials 

The Mount Sinai Crohn’s and Colitis Registry (MSCCR)

Mount Sinai has always been on the forefront of the research and treatment of inflammatory bowel disease (IBD) like Crohn’s disease and ulcerative colitis. As part of our efforts to better understand these diseases and develop new therapies for IBD, The Icahn School of Medicine at Mount Sinai has developed The Mount Sinai Crohn’s and Colitis Registry (MSCCR). The goal of this innovative study is to create a database of clinical information and a repository of biological specimens for genetic, molecular and microbiological research to better understand IBD and help develop new therapies. Patients who are not diagnosed with IBD but undergoing a colonoscopy can also participate and contribute to making a difference!

If you are interested in participating please feel free to reach out to us:
Anabella Castillo, RN, MPH
Senior Nurse Coordinator

Farah Fasihuddin, MPH
Senior Clinical Coordinator

The MSCCR team is located at:
The Susan and Leonard Feinstein IBD Center
17 East 102nd Street 5th Floor
New York, NY 10029

Meet the Research Team

Jean-Frédéric Colombel, MD
Marla C Dubinsky, MD
Bruce Sands,MD,MS
Judy H Cho,MD
Jose Clemente, MD
Jeremiah Faith, PhD
Inga Peter,MD
Keith J Benkov,MD
Joana Torres,MD
Asher Kornbluth,MD
James F Marion,MD
Anthony Weiss,MD
Peter H Rubin,MD
James Aisenberg,MD
James George,MD
Peter E Legnani,MD
Ryan C. Ungaro, MD